Sun Pharma acquires Organon

Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Pending. Sector: pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.

This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.

Gold Rate Today Sun Pharma explores $ 10 - billion Organon acquisition to boost US presence : Report Sun Pharma has engaged a European bank as an advisor to structure a comprehensive financial proposal that may be presented to Organon board Moneycontrol News January 20, 2026 / 09:31 IST The proposed transaction, estimated at around $ 10 billion including debt, could emerge as the boldest acquisition yet by Sun Pharma founder Dilip Shanghvi, 70, who is widely regarded for his sharp deal-making skills Sun Pharma is considering a $ 10 billion acquisition of US-based Organon